Logo image
Effect of protein kinase C inhibitors on endothelin- and vasopressin-induced constriction of the rat basilar artery
Journal article   Peer reviewed

Effect of protein kinase C inhibitors on endothelin- and vasopressin-induced constriction of the rat basilar artery

Margaret A Murray, Frank M Faraci and Donald D Heistad
The American journal of physiology, Vol.263(6 Pt 2), pp.H1643-H1649
12/1992
DOI: 10.1152/ajpheart.1992.263.6.H1643
PMID: 1481891

View Online

Abstract

The goal of this study was to determine whether inhibitors of protein kinase C (PKC) attenuate constrictor responses of the basilar artery in vivo to endothelin and arginine vasopressin. In anesthetized rats, the diameter of basilar arteries was measured through a cranial window [control diameter 218 +/- 3 (SE) microns]. Vessel diameter was measured during topical application of agonists and antagonists. Sphingosine (10(-6) M), a PKC inhibitor that binds to the regulatory site of PKC, attenuated vasoconstriction in response to endothelin (10(-9), 10(-8), and 10(-7) M) and vasopressin (10(-9) and 10(-8) M). H-7 (10(-9) M), a PKC inhibitor that binds to the catalytic site of PKC, also inhibited vasoconstriction in response to endothelin and vasopressin. Sphingosine and H-7 did not affect baseline diameter and did not attenuate vasoconstriction in response to prostaglandin (PG) F2 alpha. The V1 antagonist [d(CH2)5Tyr(Me)]arginine vasopressin (10(-8) M) significantly inhibited constriction in response to vasopressin (10(-9) and 10(-8) M) but not PGF2 alpha (10(-6) M). These observations suggest that activation of PKC may contribute to endothelin-induced constriction of the basilar artery in vivo and that PKC may also be a mediator of V1-receptor-mediated constriction of the basilar artery in response to vasopressin.
Sphingosine - pharmacology Basilar Artery - drug effects Animals Isoquinolines - pharmacology Endothelins - pharmacology Rats Male Protein Kinase C - antagonists & inhibitors 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine Arginine Vasopressin - pharmacology Piperazines - pharmacology Vasoconstriction - drug effects

Details

Metrics

Logo image